Literature DB >> 8976306

Continuous-scale physical functional performance in healthy older adults: a validation study.

M E Cress1, D M Buchner, K A Questad, P C Esselman, B J deLateur, R S Schwartz.   

Abstract

OBJECTIVE: The continuous-scale physical functional performance test (CS-PFP) is an original instrument designed to provide a comprehensive, in-depth measure of physical function that reflects abilities in several separate physical domains. It is based on a concept of physical function as the integration of physiological capacity, physical performance, and psychosocial factors.
SETTING: The test was administered under standard conditions in a hospital facility with a neighborhood setting. The CS-PFP consists of a battery of 15 everyday tasks, ranging from easy to demanding, that sample the physical domains of upper and lower body strength, upper body flexibility, balance and coordination, and endurance. Participants are told to work safely but at maximal effort, and physical functional performance was measured as weight, time, or distance. Scores were standardized and scaled 0 to 12. The test yields a total score and separate physical domain scores.
DESIGN: The CS-PFP was evaluated using 148 older adults-78 community dwellers, 31 long-term care facility residents living independently, and 39 residents with some dependence. MAIN OUTCOME MEASURES: Maximal physical performance assessment included measures of maximal oxygen consumption (VO2max), isokinetic strength, range of motion, gait, and balance. Psychosocial factors were measured as self-defined health status using the Sickness Impact Profile (SIP), self-perceived function using the Health Survey (SF36), and Instrumental Activities of Daily Living (IADL).
RESULTS: IADL scores were not significantly different among the groups. Test-retest correlations ranged from .84 to .97 and inter-rater reliability from .92 to .99 for the CS-PFP total and 5 domains. Internal consistency was high (Cronbach's alpha, .74 to .97). Both total and individual domain CS-PFP scores were significantly different for the three groups of study participants, increasing with higher levels of independence, supporting construct validity. CS-PFP domain scores were significantly correlated with measures of maximal physical performance (VO2max, strength, etc) and with physical but not emotional aspects of self-perceived function.
CONCLUSION: The CS-PFP is a valid, reliable measure of physical function, applicable to a wide range of functional levels, and having minimal floor and ceiling effect. The total and physical domains may be used to evaluate, discriminate, and predict physical functional performance for both research and clinical purposes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8976306     DOI: 10.1016/s0003-9993(96)90187-2

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  39 in total

1.  A Randomized Trial of an Intensive Physical Therapy Program for Patients with Acute Respiratory Failure.

Authors:  Marc Moss; Amy Nordon-Craft; Dan Malone; David Van Pelt; Stephen K Frankel; Mary Laird Warner; Wendy Kriekels; Monica McNulty; Diane L Fairclough; Margaret Schenkman
Journal:  Am J Respir Crit Care Med       Date:  2016-05-15       Impact factor: 21.405

2.  The Safe Functional Motion test is reliable for assessment of functional movements in individuals at risk for osteoporotic fracture.

Authors:  Norma J MacIntyre; Carrie L Stavness; Jonathan D Adachi
Journal:  Clin Rheumatol       Date:  2009-10-30       Impact factor: 2.980

3.  Brachial artery retrograde flow increases with age: relationship to physical function.

Authors:  Daniel P Credeur; Devon A Dobrosielski; Arturo A Arce-Esquivel; Michael A Welsch
Journal:  Eur J Appl Physiol       Date:  2009-06-30       Impact factor: 3.078

4.  A combined aerobic and resistance exercise program improves physical functional performance in patients with heart failure: a pilot study.

Authors:  Rebecca A Gary; M Elaine Cress; Melinda K Higgins; Andrew L Smith; Sandra B Dunbar
Journal:  J Cardiovasc Nurs       Date:  2012 Sep-Oct       Impact factor: 2.083

5.  The Virtual Short Physical Performance Battery.

Authors:  Anthony P Marsh; Abbie P Wrights; Eric H Haakonssen; Meredith A Dobrosielski; Elizabeth A Chmelo; Ryan T Barnard; Anthony Pecorella; Edward H Ip; W Jack Rejeski
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-03-31       Impact factor: 6.053

6.  Anaerobic power and muscle strength in human immunodeficiency virus-positive preadolescents.

Authors:  Edwardo Ramos; Suzanne Guttierrez-Teissoonniere; Jose G Conde; Jose A Baez-Cordova; Brenda Guzman-Villar; Edgar Lopategui-Corsino; Walter R Frontera
Journal:  PM R       Date:  2012-02-23       Impact factor: 2.298

7.  Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels.

Authors:  Kerry L Hildreth; Daniel W Barry; Kerrie L Moreau; Joseph Vande Griend; Randall B Meacham; Tammie Nakamura; Pamela Wolfe; Wendy M Kohrt; J Mark Ruscin; John Kittelson; M Elaine Cress; Robert Ballard; Robert S Schwartz
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

8.  High-resolution tracking of motor disorders in Parkinson's disease during unconstrained activity.

Authors:  Serge H Roy; Bryan T Cole; L Don Gilmore; Carlo J De Luca; Cathi A Thomas; Marie M Saint-Hilaire; S Hamid Nawab
Journal:  Mov Disord       Date:  2013-03-20       Impact factor: 10.338

Review 9.  Efficacy of progressive resistance training on balance performance in older adults : a systematic review of randomized controlled trials.

Authors:  Rhonda Orr; Jacqui Raymond; Maria Fiatarone Singh
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

10.  Relative contributions of adiposity and muscularity to physical function in community-dwelling older adults.

Authors:  Catherine M Jankowski; Wendolyn S Gozansky; Rachael E Van Pelt; Margaret L Schenkman; Pamela Wolfe; Robert S Schwartz; Wendy M Kohrt
Journal:  Obesity (Silver Spring)       Date:  2008-02-21       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.